Experiences of Parkinson's disease in India

Lancet Neurology

Volumn 1, Issue 4, 2002, Pages 258-262

  Behari, Madhuri ^a   Bhatnagar, S P ^c   Muthane, Uday ^b   Deo, Diwakar ^c  

^a All India Intl Medical Service   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; APOMORPHINE; BROMOCRIPTINE; CARBIDOPA; DIETHYLCARBAMAZINE; LEVODOPA; PERGOLIDE; TRIHEXYPHENIDYL;

BIOAVAILABILITY; BRAIN DEPTH STIMULATION; CONTROLLED DRUG RELEASE; DISEASE COURSE; DRUG FORMULATION; HUMAN; INDIA; NONHUMAN; PARKINSON DISEASE; PHYSICIAN; PRIORITY JOURNAL; REDUCTION; REVIEW; RISK FACTOR; STEM CELL; ADULT; ARTICLE; CASE REPORT; FEMALE; LIFE EVENT; MALE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; FEMALE; HUMANS; INDIA; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0042890600     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00105-9     Document Type: Note

References (15)

1. Bharucha N.E., Bharucha E.P., Bharucha A.E., Bhise A.V., Shoenberg B.S. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol. 45:1988;1321-1323.
2. Austin J.A. Why patients use alternative medicine: results of a national study. JAMA. 279:1998;1548-1553.
3. Vincent C., Furnham A. Why do patients turn to complementary medicine? An emperical study. Br J Clin Psychol. 35:1996;37-48.
4. Rajendran P.R., Thompson R.E., Reich S.G. The use of alternative therapy in patients with Parkinson's disease. Neurology. 57:2001;790-794.
5. Dizdar N., Kagedal B., Lindvall B. Treatment of Parkinson's disease with NADH. Acta Neurol Scand. 90:1994;345-347.
6. Census India. Government of India; 2001. http://www.censusindia.net/results/2001_Census_Data_Release_List.htm (Accessed June 27, 2002).
7. Hughes A.J., Daniel S.E., Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology. 57:2001;1497-1499.
8. Pang T., Lansang M.A., Haines A. Brain drain and health professionals. BMJ. 324:2002;499-500.
9. Karanata Goverment Medical Officers Association. http://www.kgmoas.com/hpok1.htm (Accessed June 27, 2002).
10. Banerjee, D. Health insurance in India: time for conscious revolution. http://www.karvy.com/articles/healthinsurancerevolution.htm (Accessed June 12, 2002).
11. Ellis RP, Alam M, Gupta I. Health Insurance in India. Economic and Political Weekly 2000; January 22: 207-17.
12. Littlefield R.S., Martin S.L., Heaton A.H. Baseline costs of Parkinson's disease in a large health-care plan. Drug Benefit Trends. 13:2002;38-44.
13. Vaidya A.B., Rajagopalan T.G., Mankodi N.A., et al. Treatment of Parkinson's disease with the cowhage plant - Mucuna pruriens Bak. Neurol India. 26:1978;171-176.
14. Loff B. Africans discuss ethics of biomedical research. Lancet. 359:2002;956.
15. Watson R. EU tries to protect developing countries from high drug costs. BMJ. 324:2002;634.